Latest Cancer treatments Stories
DALLAS, April 10, 2015 /PRNewswire/ -- Lifescienceindustryresearch.com adds Global & USA Cancer Immunotherapy Market Analysis to 2020 a new research report in its store.
NEW YORK, April 10, 2015 /PRNewswire/ -- Delcath Systems, Inc.
New research report “Global & USA Cancer Immunotherapy Market Analysis to 2020: Antibody Drug Conjugates (ADCs), Bispecific Monoclonal Antibodies, Cancer Vaccines, Cytokines, Interferons,
Hospital in the Netherlands To Begin Enrolling Patients NEW YORK, April 2, 2015 /PRNewswire/ -- Delcath Systems, Inc.
Scientists say an intensified dosing schedule of a monoclonal antibody called tremelimumab may be the key to fighting advanced mesothelioma when chemotherapy fails. Raleigh,
GERMANTOWN, Md., April 1, 2015 /PRNewswire/ -- Intrexon Corporation (NYSE: XON), a leader in synthetic biology, today announced
LUGANO, Switzerland, March 30, 2015 /PRNewswire/ -- First New Fixed Dose Combination Targeting Two Key Pathways Involved in CINV Helsinn, the Swiss Group
Key data confirming Cantrixil kills ovarian cancer stem cells SYDNEY, March 30, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT; NASDAQ:NVGN) and
Alexander Chi, MD, a thoracic radiation oncologist at West Virginia University, is the principal investigator in the study of novel treatment approaches for non-small cell lung cancer.
- An armed gangster.
More Images (3 images) »